Fundraising Fox
Alkemist Bio
Founded 2023 · 6 employees on LinkedIn · 4 known investors
Find your way into Alkemist Bio
Sign up to see every warm intro you have to Alkemist Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Alkemist Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ALKemist Bio develops immunotherapies targeting the ALK oncogene in cancer by engineering autologous T cells with synthetic receptors to recognize and eliminate ALK-positive tumor cells. The company's approach aims to address ALK-driven cancers including lymphoma, neuroblastoma, and non-small cell lung cancer.
Founders & leadership
Alkemist Bio was founded in 2023 by Roberto Chiarle.
RC
Roberto Chiarle
Investors · 4
Claris Ventureslisted by Claris VenturesTorino
How we know: Claris Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does Alkemist Bio do?
- ALKemist Bio develops immunotherapies targeting the ALK oncogene in cancer by engineering autologous T cells with synthetic receptors to recognize and eliminate ALK-positive tumor cells. The company's approach aims to address ALK-driven cancers including lymphoma, neuroblastoma, and non-small cell lung cancer.
- Who founded Alkemist Bio?
- Alkemist Bio was founded by Roberto Chiarle in 2023.
- Who are Alkemist Bio's investors?
- Alkemist Bio's investors include Claris Ventures, Club degli Investitori, Italian Angels for Growth, LIFTT.